Abstract:BACKGROUND Antihypertensive bisoprolol fumarate and perindopril arginine were simultaneously determined in their pure, bulk, and combined tablet dosage form. OBJECTIVE This study develops a novel, reproducible, and accurate RP-HPLC and RP-UPLC with photodiode array detection techniques, which were then applied to in vitro dissolving studies. METHOD The first RP-HPLC method relied on isocratic elution using a mobile phase consisting of methanol and 0.05M phosphate buffer pH 2.6 (50:50 v/v), and separation was done by a stationary phase Thermo Hypersil C8 column (150 mm × 4.6 mm, 5 μm). Ion-pair UPLC was the second method. An acceptable resolution was achieved using RP-C18 chromatographic column Agilent Eclipse (100 ×2.1 mm, 1.7 μm) with a mobile phase containing 0.005 M sodium 1-heptane sulfonate and 1 mL of triethylamine in the aqueous phase at pH 2.0 and acetonitrile (65:35 v/v). RP-HPLC was equipped with a 1.0 mL/min flow rate, while UPLC had 0.5 mL/min, and the two methods were detected at 210 nm. RESULTS Bisoprolol fumarate and perindopril arginine were linear for RP-HPLC and RP-UPLC at 0.5-15 and 0.5-40 μg/mL, respectively. RP-HPLC LODs were 0.16 μg/mL and 0.12 μg/mL, and LOQs were 0.47 and 0.37 μg/mL. Bisoprolol fumarate and Perindopril Arginine had RP-UPLC LODs of 0.22 and 0.10 μg/mL, respectively, and LOQs of 0.68 and 0.31 μg/mL. As a result, the approach has been effectively applied to in vitro dissolution testing for drugs in the generic and reference products, showing that the two products are comparable. The six sigma approach was implemented to compare the recommended and USP procedures, which both exhibited Cpk >1.33. A content uniformity test demonstrated that the drugs in their dosage form met the acceptance limit (85-115%). The degradation products were reliably distinguished from pure drugs for a range of retention times. CONCLUSION In their commercial drug product, these would be useful in quality control laboratories for concurrent testing, content uniformity, and in vitro dissolution investigations of bisoprolol fumarate and Perindopril Arginine. The methods were successfully validated per ICH guidelines. HIGHLIGHTS This study is innovative since it is the first to establish and validate specific and reproducible UPLC and HPLC methods for the concurrent quantitative of the studied drugs in their binary mixture and application to lean six sigma, content uniformity, and comparative dissolution approaches.

Identification, synthesis and characterization of process related impurities of benidipine hydrochloride, stress-testing/stability studies and HPLC/UPLC method validations

Stability Indicating RP-UPLC Method for the Quantitative Determination of Degradation Impurities of Benidipine Hydrochloride & Metoprolol Succinate in Combined Dosage Form

Stability-Indicating HPTLC Method for Estimation of Benazepril in Bulk and Tablet Dosage Form

Voltammetric and RP-LC assay for determination of benidipine HCl

Synthesis and Characterization of Impurities of Barnidipine Hydrochloride, an Antihypertensive Drug Substance

Stability-indicating HPLC method optimization using quality by design with design of experiments approach for quantitative estimation of organic related impurities of Doripenem in pharmaceutical formulations

STABILITY INDICATING UPLC METHOD FOR ESTIMATION OF BENAZEPRIL AND HYDROCHLOROTHIAZIDE IN BULK AND COMBINED DOSAGE FORM

Stability‐indicating RP‐HPLC method development and validation for the quantification of amlodipine besylate and valsartan tablets in solid oral dosage form

An Isolated Method and Assignment for Critical Impurities in Semi-Synthetic Process of Arbekacin Sulfate.

Development of novel gradient RP-HPLC method for separation of dapagliflozin and its process-related impurities: insight into stability profile and degradation pathway, identification of degradants using LCMS

A New and Rapid UV-Visible Spectrophotometric Method for Benidipine Hydrochloride Determination: Development and Validation

Development, stability-indicating assessment, and evaluation of influential method conditions using a full factorial design for the determination of Nintedanib esylate-related impurities

A new validated RP-HPLC-UV DAD method for assay of bisoprolol fumarate and related substances in tablets

Stability-indicating HPTLC method for the simultaneous detection and quantification of alfuzosin hydrochloride, solifenacin succinate along with four of their official impurities

Chromatographic Techniques for Assessment of Bisoprolol Fumarate and Perindopril Arginine in Solid Formulations Under Various Stress Conditions and Application to Six Sigma, Content Uniformity, and Comparative Dissolution Approaches.

AQbD TLC-densitometric method approach along with green fingerprint and whiteness assessment for quantifying two combined antihypertensive agents and their impurities

Stability-Indicating RP-HPLC Method Development, Qbd Optimization and Validation for assessing Related Impurities in Labetalol Hydrochloride bulk and injectable form

Characterization of Forced Degradation Products of Netarsudil: Optimization and Validation of a Stability-Indicating RP-HPLC Method for Simultaneous Quantification of Process-Related Impurities

Unveiling Impurities: A Comprehensive RP-HPLC Method for Accurate Atorvastatin Impurity Analysis in Pharmaceuticals Using Accuracy Profile Approach

Development and validation method for the determination of related substances in nimesulide granules for oral suspension

Physico-chemical properties and stabilities of the highly potent calcium antagonist benidipine hydrochloride